Sarepta Therapeutics Inc XNAS: SRPT

Expensive Underperformer

Download real time

17.54 -1.27 (-6.75%)

87.36% Fall from 52W High

4.4M

XNAS Volume

XNAS 17 Nov, 2025 4:30 PM (EST)

Sarepta Therapeutics Inc quarterly and annual earnings report: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents